SCHEMBL1890891

SCHEMBL1890891

COc1ccccc1Oc1cccc(C(C)C(=O)O)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 5/20 0.73
KMT2A Q03164 2/20 0.55
MEN1 O00255 1/20 0.55
CYP2D6 P10635 1/20 0.55
AKR1C3 P42330 6/20 0.54
AKR1C2 P52895 6/20 0.54
PTGS2 P35354 5/20 0.50
MAPT P10636 2/20 0.50
CXCR1 P25024 2/20 0.50
CXCR2 P25025 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
SLC22A6 Q4U2R8 2/20 0.50
LMNA P02545 2/20 0.50
RECQL P46063 1/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP3A4 P08684 1/20 0.50
HPGD P15428 1/20 0.50
MAPK1 P28482 1/20 0.50
PMP22 Q01453 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1879280 0.89 PTGS1 (0.56) PTGS1KMT2AMEN1CYP2D6AKR1C3
SCHEMBL1879281 0.89 PTGS1 (0.56) PTGS1KMT2AMEN1CYP2D6AKR1C3
Fenoprofen SCHEMBL8754928 0.85 PTGS1 (1.00) PTGS1KMT2AMEN1CYP2D6AKR1C3
R-Fenoprofen SCHEMBL4082 0.85 PTGS1 (1.00) PTGS1KMT2AMEN1CYP2D6AKR1C3
R-Fenoprofen SCHEMBL30910976 0.85 PTGS1 (1.00) PTGS1KMT2AMEN1CYP2D6AKR1C3
Fenoprofen SCHEMBL11336376 0.85 PTGS1 (1.00) PTGS1KMT2AMEN1CYP2D6AKR1C3
Fenoprofen SCHEMBL3797 0.85 PTGS1 (1.00) PTGS1KMT2AMEN1CYP2D6AKR1C3
(S)-Fenoprofen SCHEMBL4492279 0.85 PTGS1 (1.00) PTGS1KMT2AMEN1CYP2D6AKR1C3
Fenoprofen SCHEMBL29481372 0.85 PTGS1 (1.00) PTGS1KMT2AMEN1CYP2D6AKR1C3
SCHEMBL11829107 0.84 PTGS1 (0.71) PTGS1KMT2AMEN1CYP2D6AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7939521-B2 2-arylpropionic acid derivatives and pharmaceutical compositions containing them DompePHA.R.MA S.p.A. (IT) 2011-05-10 US disclosed
EP-1856031-B1 2-ARYLPROPIONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMPE PHA R MA SPA RES & MFG (IT) 2009-02-25 EP disclosed
US-20080312293-A1 2-Arylpropionic Acid Derivatives and Pharmaceutical Compositions Containing Them DOMPE' PHA.R.MA.S.P.A. (IT) 2008-12-18 US disclosed
EP-1856031-A1 2-ARYLPROPIONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMPE' pha.r.ma s.p.a. (IT) 2007-11-21 EP disclosed
WO-2006063999-A1 2-ARYLPROPIONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMPE' PHA.R.MA.S.P.A. (IT) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312293-A1 2-Arylpropionic Acid Derivatives and Pharmaceutical Compositions Containing Them C3AR1, C5AR2, C5AR1 PTGS1 197/4885KMT2A 4725/4885MEN1 4729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.